Publisher Correction: Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial.

Sun Y, Zhong J, Sun H, Parr G, Lukacs E, Slade D, Zhou Y, Ren X, Kirk D, Kmieciak A, Yao T, Wang J

Open source

DOI: 10.1007/s40487-026-00461-8
Published: 2026 Sep
Container: Oncology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40487-026-00461-8,
  title = {Publisher Correction: Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial.},
  author = {Sun Y and Zhong J and Sun H and Parr G and Lukacs E and Slade D and Zhou Y and Ren X and Kirk D and Kmieciak A and Yao T and Wang J},
  year = {2026},
  journal = {Oncology and therapy},
  doi = {10.1007/s40487-026-00461-8},
  url = {https://doi.org/10.1007/s40487-026-00461-8}
}

RIS

TY  - JOUR
TI  - Publisher Correction: Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial.
AU  - Sun Y
AU  - Zhong J
AU  - Sun H
AU  - Parr G
AU  - Lukacs E
AU  - Slade D
AU  - Zhou Y
AU  - Ren X
AU  - Kirk D
AU  - Kmieciak A
AU  - Yao T
AU  - Wang J
PY  - 2026
JO  - Oncology and therapy
DO  - 10.1007/s40487-026-00461-8
UR  - https://doi.org/10.1007/s40487-026-00461-8
ER  -

APA

Y, S., J, Z., H, S., G, P., E, L., D, S., Y, Z., X, R., D, K., A, K., T, Y., & J, W. (2026). Publisher Correction: Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial.. Oncology and therapy. https://doi.org/10.1007/s40487-026-00461-8

Source records

pubmed · retrieved 2026-09-26T14:07:24.512Z
europe-pmc · retrieved 2026-09-26T14:07:24.500Z
doaj · retrieved 2026-09-26T14:07:24.482Z